Table of Contents

Part I: Prevention and Diagnosis; 1. Nutrition, lifestyle interventions and prevention. J Brooks; 2. Clinical markers for prostate cancer. R Getzenberg; 3. Histopathological markers and precursor lesions. D Bostwick; 4. Screening for prostate cancer. P Albertsen; Part II: Regional prostate cancer - localised and locally advanced prostate cancer; 5. Risk categories - therapeutic implications. M Kattan; 6. Conservative strategies. L Klotz; 7. Treatment strategies for low risk prostate cancer. M Soloway; 8. Treatment strategies for high risk prostate cancer. M Feneley, H Payne; 9. Treatment strategies for biochemical recurrence of prostate cancer. V Khoo; Part III: Advanced prostate cancer - distant metastases; 10. Endpoints for clinical trials. K Chi, M Gleave; 11. Hormonal strategies for treatment of advanced disease. D Gillat; 12. Chemotherapy strategies for treatment of advanced disease. M Carducci, A Armstrong; 13. Molecular strategies and future trials for treatment of advanced disease. D Newling; 14. Therapeutics strategies of palliative care and quality of life for advanced prostate cancer. C Farnham, O Al-Salihi, F Lim; Part IV: Management of complications; 15. Treatment strategies for spinal cord compression and fractures. A Stirling; 16. Treatment strategies for urinary obstruction. R Kirby; 17. Treatment strategies for erectile dysfunction. A Burnett; 18. Treatment strategies for pain control. J O'Sullivan; Abbreviations; Index.

About the Author

M Feneley, Institute of Urology, University College London, London, UK. H Payne, Institute of Urology, Meyerstein Institute of Oncology, University College London, London, UK.